Ardentlife Pharmaceutical Private Limited - Company Profile

It is a pharma private limited company based in Pune City, Maharashtra, India, established in 2024.
2024 Pune City, Maharashtra, India Active
Last Updated:
Access Report
About Ardentlife Pharmaceutical Private Limited

Ardentlife Pharmaceutical Private Limited, a active private limited company, was established on 05 July 2024 in Pune City, Maharashtra, India. Engaging in pharmaceutical retailers & distributors within the pharma sector, it holds CIN: U21000PN2024PTC232497. Registered under ROC Roc Pune. it is unlisted. It has an authorized capital of ₹0.50 M and a paid-up capital of ₹0.15 M.

Its leadership includes Supriya Baran Chanda (Additional Director), Vijay Singh Patel (Director), Subhash Sopanrao Suryawanshi (Director). It is based at Bldg No-4,Flat No- 203 'F, Residences Wadgaonsher, Pune City, Maharashtra, 411014.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U21000PN2024PTC232497

  • Registration Number

    232497

  • Incorporation Date

    05 July 2024

  • Authorized Capital

    ₹0.50 M

  • Paid-Up Capital

    ₹0.15 M

  • ROC Code

    Roc Pune

  • Listing Status

    Unlisted

  • Company Status

    Active

Key Metrics
  • Authorised Capital ₹ 0.50 M
  • Paid Up Capital ₹ 0.15 M
  • Company Age 1 Year 7 Months
Company report

Ardentlife Pharmaceutical Private Limited

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Ardentlife Pharmaceutical Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report
Who are the key members and board of directors at Ardentlife Pharmaceutical Private Limited?
Current Directors
Name Designation Appointment Date Status
Supriya Baran Chanda Additional Director 12 Aug 2025 Current
Vijay Singh Patel Director 05 Jul 2024 Current
Subhash Sopanrao Suryawanshi Director 05 Jul 2024 Current

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Ardentlife Pharmaceutical.

Enhance accessibility to Ardentlife Pharmaceutical's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.

Ardentlife Pharmaceutical revenue growth over time
Ardentlife Pharmaceutical profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
*******
*******
*******
*******
*******
Revenue from Operations
*******
*******
*******
*******
*******
*******
Total Assets
*******
*******
*******
*******
*******
*******
Profit or Loss
*******
*******
*******
*******
*******
*******
Net Worth
*******
*******
*******
*******
*******
*******
EBITDA
*******
*******
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Ardentlife Pharmaceutical?

Unlock access to Ardentlife Pharmaceutical's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

How Many Employees Work at Ardentlife Pharmaceutical?

Unlock and access historical data on people associated with Ardentlife Pharmaceutical, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Ardentlife Pharmaceutical, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Ardentlife Pharmaceutical's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Ardentlife Pharmaceutical
Recent Activity within the Organization
  • Director Appointment

    Progress on Supriya Baran Chanda was appointed as a Additional Director was appointed as a Additional Director on 12 Aug 2025 & has been associated with this company since 6 months 12 days . was documented.

  • Director Appointment

    Progress on Vijay Singh Patel was appointed as a Director was appointed as a Director on 05 Jul 2024 & has been associated with this company since 1 year 7 months . was documented.

  • Director Appointment

    The activity Subhash Sopanrao Suryawanshi was appointed as a Director was appointed as a Director on 05 Jul 2024 & has been associated with this company since 1 year 7 months . was completed.

  • Company Incorporation

    Progress on Ardentlife Pharmaceutical Private Limited was registered on 05 Jul 2024 with Roc Pune & aged 1 year 7 months as per MCA records. was documented.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Ardentlife Pharmaceutical Private Limited?

The CIN of Ardentlife Pharmaceutical Private Limited is U21000PN2024PTC232497.

Where is Ardentlife Pharmaceutical Private Limited headquartered?

Ardentlife Pharmaceutical Private Limited is headquartered at Bldg No-4,Flat No- 203 'F, Residences Wadgaonsher, Pune City, Maharashtra, 411014.

When was Ardentlife Pharmaceutical Private Limited incorporated?

Ardentlife Pharmaceutical Private Limited was incorporated on 05 July 2024.

Who are the current directors of Ardentlife Pharmaceutical Private Limited?

The current directors of Ardentlife Pharmaceutical Private Limited are

What is the primary industry of Ardentlife Pharmaceutical Private Limited?

The primary industry of Ardentlife Pharmaceutical Private Limited is Pharma.

Is Ardentlife Pharmaceutical Private Limited a listed company?

Ardentlife Pharmaceutical Private Limited is unlisted.

What is the capital structure of Ardentlife Pharmaceutical Private Limited?

The authorized capital of Ardentlife Pharmaceutical Private Limited is ₹0.50 M, and the paid-up capital is ₹0.15 M.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available